2023 Form 5500 filing — Osborn Drugs Employee 401(K) Profit Sharing Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240923152122NAL0011536497001) for Osborn Drugs Employee 401(K) Profit Sharing Plan, reported by Osborn Drugs, Inc. under EIN 73-0802911 and plan number 001. It reports 251 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240923152122NAL0011536497001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Osborn Drugs, Inc.
- EIN
- 73-0802911
- Plan number
- 001
- Location
- Miami, OK
- Participants
- 251
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $24,502,345
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $24,502,345
- Employer contributions
- $303,107
- Participant contributions
- $706,832
- Total income / additions
- $3,901,613
- Benefits paid
- $243,557
- Administrative expenses
- $175
- Total expenses
- $243,732
- Net increase / (decrease)
- $3,657,881
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Ubs Financial Services Inc | ADVISOR | $0 | $50,369 |
| Fidelity Investments Institutional | RECORDKEEPER | $175 | $0 |